iBio Statistics
NASDAQ: IBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.01-0.04 (-3.81%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.98 -2.97%
iBio by the numbers
iBio has a market capitalization of $65.0 million based on 64.31M shares outstanding. With trailing EPS of $-0.32, iBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.3% below its 50-day average and 44.2% below its 200-day average.
Average daily trading volume is 704.06K shares, or about $711,102 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IBIO valuation vs. peer median
| Metric | IBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $64.95M | $67.40M | -4% |
| Avg. volume | 704.06K | 402.02K | +75% |
Peer median across 8 companies: XBIT, APLM, GOSS, FBIO, RNTX, RNXT, SPRO, NMAD.
Valuation
- Market cap
- $64.95M
- EPS (TTM)
- $-0.32
- Shares outstanding
- 64.31M
Price and trading
- Previous close
- 1.05
- Open
- 1.05
- Day range
- 0.97 – 1.06
- 52-week range
- 0.78 – 3.82
- 52-week change
- +16.09%
- Beta
- —
- Volume
- 2.71M
- Average volume
- 704.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 18, 2025
Additional statistics
- Market Cap
- 64.95M
- Forward Pe
- -1.64
- Eps
- -0.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.82
- Week52 Low
- 0.78
- Avg Volume
- 704.06K
- Shares Outstanding
- 64.31M
- Ma50
- 1.32
- Ma200
- 1.81
- Earnings Date
- Sep 18, 2025
- Pct From52w High
- -73.56%
- Pct From52w Low
- 29.49%